Raily Aesthetic Medicine International Holdings Limited (HK:2135) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Raily Aesthetic Medicine International Holdings Limited announced the disposal of its subsidiary, Jiumei Xinhe, resulting in an estimated net loss of RMB740.55. The proceeds from this transaction will be utilized as general working capital for the company. This move reflects the company’s strategic adjustments amidst challenging financial conditions.
For further insights into HK:2135 stock, check out TipRanks’ Stock Analysis page.